Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 11 results
Filters: First Letter Of Title is V  [Clear All Filters]
Found 11 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

V

Mrus JM, Schackman BR, Wu AW, et al. "Variations in self-rated health among patients with HIV infection." Qual Life Res. 2006;15(3):503-14.
Yeh T-min, Evans SR, Gulick RM, Clifford DB. "Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211." HIV Clin Trials. 2010;11(1):51-8.
Tsibris AMN, Hu Z, Paredes R, et al. "Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures." J. Virol.. 2012;86(12):6416-26.
Blackard JT, Kang M, J St Clair B, et al. "Viral factors associated with cytokine expression during HCV/HIV co-infection." J. Interferon Cytokine Res.. 2007;27(4):263-9.
Cillo AR, Hilldorfer BB, Lalama CM, et al. "Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery." AIDS. 2015;29(16):2121-9.
Markowitz M, Vaida F, C Hare B, et al. "The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection." J. Infect. Dis.. 2010;201(9):1298-302.
Kang M, Hollabaugh K, Pham V, et al. "Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort." J. Acquir. Immune Defic. Syndr.. 2014;66(2):172-80.
Hu Z, Hatano H, Hammond SP, et al. "Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase." J. Acquir. Immune Defic. Syndr.. 2007;45(5):494-500.
Mitsuyasu R, Gelman R, Cherng DWeng, et al. "The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328." Arch. Intern. Med.. 2007;167(6):597-605.
Overton ETurner, Chan ES, Brown TT, et al. "Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial." Ann. Intern. Med.. 2015;162(12):815-24.
Natsag J, Kendall MA, Sellmeyer DE, McComsey GA, Brown TT. "Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density." HIV Med.. 2016;17(3):196-205.